Transcriptional Signatures of Tau and Amyloid Neuropathology
Author(s) -
Isabel Castanho,
Tracey K. Murray,
Eilís Han,
Aaron R. Jeffries,
Emma Walker,
Emma Laing,
Hedley Baulf,
Joshua Harvey,
Lauren Bradshaw,
Andrew D. Randall,
Karen Moore,
Paul O’Neill,
Katie Lun,
David Collier,
Zeshan Ahmed,
Michael J. O’Neill,
Jonathan Mill
Publication year - 2020
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2020.01.063
Subject(s) - neuropathology , neuroscience , amyloid (mycology) , biology , computational biology , medicine , bioinformatics , pathology , disease
Alzheimer's disease (AD) is associated with the intracellular aggregation of hyperphosphorylated tau and the accumulation of β-amyloid in the neocortex. We use transgenic mice harboring human tau (rTg4510) and amyloid precursor protein (J20) mutations to investigate transcriptional changes associated with the progression of tau and amyloid pathology. rTg4510 mice are characterized by widespread transcriptional differences in the entorhinal cortex with changes paralleling neuropathological burden across multiple brain regions. Differentially expressed transcripts overlap with genes identified in genetic studies of familial and sporadic AD. Systems-level analyses identify discrete co-expression networks associated with the progressive accumulation of tau that are enriched for genes and pathways previously implicated in AD pathology and overlap with co-expression networks identified in human AD cortex. Our data provide further evidence for an immune-response component in the accumulation of tau and reveal molecular pathways associated with the progression of AD neuropathology.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom